Michigan health insurance companies sign letter of intent to merge

Michael Walter | | Health Exec | Economics

Two Michigan-based health insurance companies, Flint-based HealthPlus of Michigan and Detroit-based Health Alliance Plan (HAP), announced that they have reached an agreement and signed a letter of intent to merge. The two companies made headlines in October when a potential merge was first announced.

“This is a win-win situation,” James Connelly, HAP president and CEO, said in a statement. “It's a win for both HealthPlus and HAP because it creates a larger, stronger, more competitive company with a solid portfolio of comprehensive products and opportunities for growth. As important, it's a win for the members of both companies because two Michigan-based non-profit companies are coming together to provide excellent coverage, care and customer service.”

According to the statement, HealthPlus members will not experience any changes to their provider networks or coverage.

The scheduled effective date for the deal is Jan. 1, 2016. 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.